المؤلفون: Friedman, Danielle Novetsky, Goodman, Pamela J, Leisenring, Wendy M, Diller, Lisa R, Cohn, Susan L, Howell, Rebecca M, Smith, Susan A, Tonorezos, Emily S, Wolden, Suzanne L, Neglia, Joseph P, Ness, Kirsten K, Gibson, Todd M, Nathan, Paul C, Turcotte, Lucie M, Weil, Brent R, Robison, Leslie L, Oeffinger, Kevin C, Armstrong, Gregory T, Sklar, Charles A, Henderson, Tara O

المصدر: JNCI: Journal of the National Cancer Institute; Jun2024, Vol. 116 Issue 6, p885-894, 10p

مصطلحات موضوعية: NEUROBLASTOMA, CHILDHOOD cancer, CANCER survivors, STEM cell transplantation, MORTALITY, REGRESSION analysis

مستخلص: Background Early efforts at risk-adapted therapy for neuroblastoma are predicted to result in differential late effects; the magnitude of these differences has not been well described. Methods Late mortality, subsequent malignant neoplasms (SMNs), and severe/life-threatening chronic health conditions (CHCs), graded according to CTCAE v4.03, were assessed among 5-year Childhood Cancer Survivor Study (CCSS) survivors of neuroblastoma diagnosed 1987-1999. Using age, stage at diagnosis, and treatment, survivors were classified into risk groups (low [n = 425]; intermediate [n = 252]; high [n = 245]). Standardized mortality ratios (SMRs) and standardized incidence ratios (SIRs) of SMNs were compared with matched population controls. Cox regression models estimated hazard ratios (HRs) and 95% confidence intervals for CHC compared with 1029 CCSS siblings. Results Among survivors (49.8% male; median age = 21 years, range = 7-42; median follow-up = 19.3 years, range = 5-29.9), 80% with low-risk disease were treated with surgery alone, whereas 79.1% with high-risk disease received surgery, radiation, chemotherapy ± autologous stem cell transplant (ASCT). All-cause mortality was elevated across risk groups (SMRhigh = 27.7 [21.4-35.8]; SMRintermediate = 3.3 [1.7-6.5]; SMRlow = 2.8 [1.7-4.8]). SMN risk was increased among high- and intermediate-risk survivors (SIRhigh = 28.0 [18.5-42.3]; SIRintermediate = 3.7 [1.2-11.3]) but did not differ from the US population for survivors of low-risk disease. Compared with siblings, survivors had an increased risk of grade 3-5 CHCs, particularly among those with high-risk disease (HRhigh = 16.1 [11.2-23.2]; HRintermediate = 6.3 [3.8-10.5]; HRlow = 1.8 [1.1-3.1]). Conclusion Survivors of high-risk disease treated in the early days of risk stratification carry a markedly elevated burden of late recurrence, SMN, and organ-related multimorbidity, whereas survivors of low/intermediate-risk disease have a modest risk of late adverse outcomes. [ABSTRACT FROM AUTHOR]

: Copyright of JNCI: Journal of the National Cancer Institute is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

المؤلفون: Goldsby, Robert E, Stratton, Kayla L, Raber, Shannon, Ablin, Arthur, Strong, Louise C, Oeffinger, Kevin, Sklar, Charles A, Armstrong, Gregory T, Robison, Leslie L, Bhatia, Smita, Leisenring, Wendy M

المصدر: Cancer. 124(3)

مصطلحات موضوعية: Pediatric, Rare Diseases, Rehabilitation, Intellectual and Developmental Disabilities (IDD), Pediatric Research Initiative, Hematology, Prevention, Brain Disorders, Pediatric Cancer, Cancer, Clinical Research, Childhood Leukemia, Down Syndrome, 2.1 Biological and endogenous factors, Aetiology, Adolescent, Adult, Cancer Survivors, Child, Chronic Disease, Female, Humans, Leukemia, Male, Middle Aged, Neoplasms, Second Primary, Proportional Hazards Models, Young Adult, Down syndrome, leukemia, late effects, chronic conditions, survivorship, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis

الوصف: BackgroundChildren with Down syndrome (DS) are at increased risk of developing acute leukemia and are more prone to acute toxicities. We studied the incidence and severity of chronic health conditions among survivors of childhood leukemia with DS compared with those without DS.MethodsChronic health conditions reported by questionnaire were compared between 154 pediatric leukemia survivors with DS and 581 without DS, matched by leukemia, age at diagnosis, race/ethnicity, sex, radiation location and chemotherapy exposure using Cox models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Subjects were selected from 7139 5-year survivors of leukemia in the Childhood Cancer Survivor Study.ResultsRisk of at least 1 late onset chronic health condition (grade 1-5) was similar in the DS population compared with the non-DS group (HR, 1.1; 95% CI, 0.7-1.5). Serious chronic health conditions (grade 3-5) were more common in DS survivors (HR, 1.7; 95% CI, 1.1-2.6), as were ≥ 3 chronic health conditions (grades 1-5) (HR, 1.7; 95% CI, 1.2-2.4). The 25-year cumulative incidence of any condition (grades 1-5) was 83% for DS survivors and 69% for non-DS survivors.ConclusionLeukemia survivors with DS have therapy-related chronic health conditions comparable to those of similarly treated survivors without DS, with a few notable exceptions: 1) an increased risk of cataracts, hearing loss, and thyroid dysfunction compared with survivors without DS (though these are known risks in the DS population), 2) decreased risk of second cancers, and 3) increased risk of severe or multiple conditions. Practitioners should be aware of these risks during and after therapy. Cancer 2018;124:617-25. © 2017 American Cancer Society.

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/0g86g8ccTest

المؤلفون: Marina, Neyssa M, Liu, Qi, Donaldson, Sarah S, Sklar, Charles A, Armstrong, Gregory T, Oeffinger, Kevin C, Leisenring, Wendy M, Ginsberg, Jill P, Henderson, Tara O, Neglia, Joseph P, Stovall, Marilyn A, Yasui, Yutaka, Randall, R Lor, Geller, David S, Robison, Leslie L, Ness, Kirsten K

المصدر: Cancer. 123(13)

مصطلحات موضوعية: Rare Diseases, Cancer, Hematology, Pediatric, Pediatric Research Initiative, Prevention, Pediatric Cancer, 2.4 Surveillance and distribution, Aetiology, Good Health and Well Being, Adolescent, Adult, Anthracyclines, Antineoplastic Agents, Bone Neoplasms, Breast Neoplasms, Child, Chronic Disease, Cohort Studies, Female, Follow-Up Studies, Heart Diseases, Humans, Leukemia, Myeloid, Acute, Longitudinal Studies, Male, Middle Aged, Mortality, Musculoskeletal Diseases, Neoplasm Recurrence, Local, Neoplasms, Second Primary, Orthopedic Procedures, Osteosarcoma, Radiotherapy, Retrospective Studies, Sarcoma, Ewing, Survivors, Thyroid Neoplasms, Young Adult, Ewing sarcoma, childhood cancer survivors, chronic health conditions, late mortality, treatment-related complications, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis

الوصف: BackgroundEwing sarcoma survivors (ESSs) are at increased risk for treatment-related complications. The incidence of treatment-related morbidity and late mortality with aging is unknown.MethodsThis study reports survival probabilities, estimated with the Kaplan-Meier method, and the cumulative incidence of cause-specific mortality and chronic conditions among ESSs in the Childhood Cancer Survivor Study who were treated between 1970 and 1986. Piecewise exponential models were used to estimate relative rates (RRs) and 95% confidence intervals (CIs) for these outcomes. Chronic conditions were graded with the Common Terminology Criteria for Adverse Events (version 4.03).ResultsAmong 404 5-year ESSs (median age at last follow-up, 34.8 years; range, 9.1-54.8 years), the 35-year survival rate was 70% (95% CI, 66%-74%). Late recurrence (cumulative incidence at 35 years, 15.1%) was the most common cause of death, and it was followed by treatment-related causes (11.2%). There were 53 patients with subsequent neoplasms (SNs; cumulative incidence at 35 years, 24.0%), and 38 were malignant (14.3% at 35 years). The standardized incidence ratios were 377.1 (95% CI, 172.1-715.9) for osteosarcoma, 28.9 (95% CI, 3.2-104.2) for acute myeloid leukemia, 14.9 (95% CI, 7.9-25.5) for breast cancer, and 13.1 (95% CI, 4.8-28.5) for thyroid cancer. Rates of chronic conditions were highest for musculoskeletal (RR, 18.1; 95% CI, 12.8-25.7) and cardiac complications (RR, 1.8; 95% CI, 1.4-2.3). Thirty-five years after the diagnosis, the cumulative incidences of any chronic conditions and 2 or more chronic conditions were 84.6% (95% CI, 80.4%-88.8%) and 73.8% (95% CI, 67.8%-79.9%), respectively.ConclusionsWith extended follow-up, ESSs' risk for late mortality and SNs does not plateau. Treatment-related chronic conditions develop years after therapy, and this supports the need for lifelong follow-up. Cancer 2017;123:2551-60. © 2017 American Cancer Society.

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/1z10p4whTest

المؤلفون: Tonorezos, Emily S., Chou, Joanne F., Moskowitz, Chaya S., Leisenring, Wendy M., Friedman, Danielle Novetsky, Sklar, Charles A., Dilley, Kimberly J., Hudson, Melissa M., Mertens, Ann, Armstrong, Gregory T., Robison, Leslie L., Meacham, Lillian R., Oeffinger, Kevin C.

المصدر: Pediatric Blood & Cancer; Aug2024, Vol. 71 Issue 8, p1-7, 7p

المؤلفون: Tonorezos, Emily S, Chou, Joanne F, Moskowitz, Chaya S, Leisenring, Wendy M, Friedman, Danielle Novetsky, Sklar, Charles A, Dilley, Kimberly J, Hudson, Melissa M, Mertens, Ann, Armstrong, Gregory T, Robison, Leslie L, Meacham, Lillian R, Oeffinger, Kevin C

المصدر: Pediatr Blood Cancer ; ISSN:1545-5017 ; Volume:71 ; Issue:8

مصطلحات موضوعية: body mass index, childhood cancer, mortality, pediatric, survivorship, underweight

الوصف: Approximately 1 in 10 adult survivors of childhood cancer is underweight. Although the consequences of being overweight or obese have been well described, outcomes among childhood cancer survivors who are underweight are unknown.

العلاقة: https://doi.org/10.1002/pbc.31080Test; https://pubmed.ncbi.nlm.nih.gov/38778453Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209777Test/

الإتاحة: https://doi.org/10.1002/pbc.31080Test
https://pubmed.ncbi.nlm.nih.gov/38778453Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209777Test/

المؤلفون: Fullerton, Heather J, Stratton, Kayla, Mueller, Sabine, Leisenring, Wendy W, Armstrong, Greg T, Weathers, Rita E, Stovall, Marilyn, Sklar, Charles A, Goldsby, Robert E, Robison, Les L, Krull, Kevin R

المصدر: Neurology. 85(12)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Neurosciences, Clinical Sciences, Pediatric, Rehabilitation, Aging, Brain Disorders, Pediatric Cancer, Cancer, Pediatric Research Initiative, Stroke, Prevention, 2.4 Surveillance and distribution, Aetiology, Adolescent, Adult, Child, Child, Preschool, Cohort Studies, Female, Follow-Up Studies, Humans, Infant, Longitudinal Studies, Male, Middle Aged, Neoplasms, Recurrence, Retrospective Studies, Survivors, Young Adult, Cognitive Sciences, Neurology & Neurosurgery, Clinical sciences

الوصف: ObjectiveTo estimate the rates and predictors of recurrent stroke among survivors of pediatric cancer who have had a first stroke.MethodsThe Childhood Cancer Survivor Study is a retrospective cohort study with longitudinal follow-up that enrolled 14,358 survivors (

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6tb5t8xqTest

المؤلفون: Madenci, Arin L, Fisher, Stacey, Diller, Lisa R, Goldsby, Robert E, Leisenring, Wendy M, Oeffinger, Kevin C, Robison, Leslie L, Sklar, Charles A, Stovall, Marilyn, Weathers, Rita E, Armstrong, Gregory T, Yasui, Yutaka, Weldon, Christopher B

المصدر: Journal of Clinical Oncology. 33(26)

مصطلحات موضوعية: Clinical Research, Rare Diseases, Digestive Diseases, Cancer, Prevention, Management of diseases and conditions, 7.1 Individual care needs, Adolescent, Adult, Child, Child, Preschool, Cohort Studies, Female, Humans, Incidence, Infant, Infant, Newborn, Intestinal Obstruction, Male, Neoplasms, Survivors, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis

الوصف: PurposeFor adult survivors of childhood cancer, knowledge about the long-term risk of intestinal obstruction from surgery, chemotherapy, and radiotherapy is limited.MethodsIntestinal obstruction requiring surgery (IOS) occurring 5 or more years after cancer diagnosis was evaluated in 12,316 5-year survivors in the Childhood Cancer Survivor Study (2,002 with and 10,314 without abdominopelvic tumors) and 4,023 sibling participants. Cumulative incidence of IOS was calculated with second malignant neoplasm, late recurrence, and death as competing risks. Using piecewise exponential models, we assessed the associations of clinical and demographic factors with rate of IOS.ResultsLate IOS was reported by 165 survivors (median age at IOS, 19 years; range, 5 to 50 years; median time from diagnosis to IOS, 13 years) and 14 siblings. The cumulative incidence of late IOS at 35 years was 5.8% (95% CI, 4.4% to 7.3%) among survivors with abdominopelvic tumors, 1.0% (95% CI, 0.7% to 1.4%) among those without abdominopelvic tumors, and 0.3% (95% CI, 0.1% to 0.5%) among siblings. Among survivors, abdominopelvic tumor (adjusted rate ratio [ARR], 3.6; 95% CI, 1.9 to 6.8; P < .001) and abdominal/pelvic radiotherapy within 5 years of cancer diagnosis (ARR, 2.4; 95% CI, 1.6 to 3.7; P < .001) increased the rate of late IOS, adjusting for diagnosis year; sex; race/ethnicity; age at diagnosis; age during follow-up (as natural cubic spline); cancer type; and chemotherapy, radiotherapy, and surgery within 5 years of cancer diagnosis. Developing late IOS increased subsequent mortality among survivors (ARR, 1.8; 95% CI, 1.1 to 2.9; P = .016), adjusting for the same factors.ConclusionThe long-term risk of IOS and its association with subsequent mortality underscore the need to promote awareness of this complication among patients and providers.

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/1tm0s58zTest

المؤلفون: Inskip, Peter D., Veiga, Lene H. S., Brenner, Alina V., Sigurdson, Alice J., Ostroumova, Evgenia, Chow, Eric J., Stovall, Marilyn, Smith, Susan A., Weathers, Rita E., Leisenring, Wendy, Robison, Leslie L., Armstrong, Gregory T., Sklar, Charles A., Lubin, Jay H.

المصدر: Radiation Research, 2018 Aug 01. 190(2), 117-132.

الوصول الحر: https://www.jstor.org/stable/48571098Test

المؤلفون: Huang, Tseng Tien, Chen, Yan, Dietz, Andrew C, Yasui, Yutaka, Donaldson, Sarah S, Stokes, Dennis C, Stovall, Marilyn, Leisenring, Wendy M, Sklar, Charles A, Diller, Lisa R, Mertens, Ann C, Armstrong, Gregory T, Green, Daniel M, Robison, Leslie L, Ness, Kirsten K

المصدر: Pediatric Blood & Cancer. 61(2)

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9vv433mfTest

المؤلفون: Stratton, Kayla, Leisenring, Wendy, Weathers, Rita, Stovall, Marilyn, Armstrong, Gregory, Packer, Roger, Sklar, Charles, Bowers, Daniel, Robison, Leslie, Krull, Kevin, Mueller, Sabine, Fullerton, Heather, Goldsby, Robert

المصدر: International Journal of Radiation Oncology - Biology - Physics. 86(4)

مصطلحات موضوعية: Adolescent, Adult, Age Factors, Atherosclerosis, Case-Control Studies, Child, Child, Preschool, Cranial Irradiation, Female, Follow-Up Studies, Humans, Hypertension, Incidence, Infant, Male, Neoplasms, Proportional Hazards Models, Retrospective Studies, Risk Factors, Stroke, Survivors, Young Adult

الوصف: PURPOSE: To test the hypotheses that (1) the increased risk of stroke conferred by childhood cranial radiation therapy (CRT) persists into adulthood; and (2) atherosclerotic risk factors further increase the stroke risk in cancer survivors. METHODS AND MATERIALS: The Childhood Cancer Survivor Study is a multi-institutional retrospective cohort study of 14,358 5-year survivors of childhood cancer and 4023 randomly selected sibling controls with longitudinal follow-up. Age-adjusted incidence rates of self-reported late-occurring (≥5 years after diagnosis) first stroke were calculated. Multivariable Cox proportional hazards models were used to identify independent stroke predictors. RESULTS: During a mean follow-up of 23.3 years, 292 survivors reported a late-occurring stroke. The age-adjusted stroke rate per 100,000 person-years was 77 (95% confidence interval [CI] 62-96), compared with 9.3 (95% CI 4-23) for siblings. Treatment with CRT increased stroke risk in a dose-dependent manner: hazard ratio 5.9 (95% CI 3.5-9.9) for 30-49 Gy CRT and 11.0 (7.4-17.0) for 50+ Gy CRT. The cumulative stroke incidence in survivors treated with 50+ Gy CRT was 1.1% (95% CI 0.4-1.8%) at 10 years after diagnosis and 12% (95% CI 8.9-15.0%) at 30 years. Hypertension increased stroke hazard by 4-fold (95% CI 2.8-5.5) and in black survivors by 16-fold (95% CI 6.9-36.6). CONCLUSION: Young adult pediatric cancer survivors have an increased stroke risk that is associated with CRT in a dose-dependent manner. Atherosclerotic risk factors enhanced this risk and should be treated aggressively.

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/3c00h35cTest
https://escholarship.org/content/qt3c00h35c/qt3c00h35c.pdfTest